In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
about
Susceptibilities of Bacteroides and Fusobacterium spp. from foot rot in goats to 10 beta-lactam antibiotics.Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis.Inactivation of cefoxitin and moxalactam by Bacteroides bivius beta-lactamase.Factors affecting the in vitro activity of cefoperazone against the Bacteroides fragilis groupIn vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin.N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteriaActivity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase productionDifferences in susceptibilities of species of the Bacteroides fragilis group to several beta-lactam antibiotics: indole production as an indicator of resistance.Susceptibility of the Bacteroides fragilis group in the United States in 1981.Cefoxitin inactivation by Bacteroides fragilis.In vitro activity of cefodizime.Isolated cell behavior drives the evolution of antibiotic resistancePharmacokinetics and transplacental passage of imipenem during pregnancy.Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals.Multiple-dose pharmacokinetics of imipenem-cilastatin.Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosisIn vitro activity of cefbuperazone compared with that of other new beta-lactam agents against anaerobic gram-negative bacilli and contribution of beta-lactamase to resistance.Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitals.Comparative in vitro activity of ceftizoxime, cefoperazone, and cefoxitin against anaerobic bacteria.In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa.In vitro activity of imipenem--a review.Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics.Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.Bactericidal activities of new beta-lactam antibiotics against Bacteroides fragilis.Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans.
P2860
Q35252670-0C7DE7AC-35F5-4586-8185-561E93619EF5Q35575606-BEA49008-9E21-4769-8BF3-AB74AF2179D6Q35575698-9B3C437A-7A24-46BC-B86C-DB9A3955287DQ35672511-54E1707E-4518-431F-890F-057427A70B8EQ35672612-85A7795C-EE40-455B-AD8F-F858BDC4A3BDQ35673370-2715BF0C-6925-4053-9D0F-2E95DD0AF6AFQ35716328-1D01192A-1788-4FF4-84BF-3E0C012A2E01Q35718303-3D7121DD-0E4E-410A-A73C-344751289BFCQ35740380-4B887DC7-1928-47DC-AD11-589F931CB1ACQ35755796-79D29A19-6A2B-421E-A64C-B3524B2DA3FBQ35842207-FE8C02E5-C958-4551-95C2-9EA173B81B74Q35991497-4B9647FF-FD63-45ED-BCD3-50E1EB62BED5Q36758177-AD6FEEBA-867F-435A-99B6-8BA4EA3A04FFQ39833748-49760823-3BB6-46D8-99C8-D4772E378564Q39849277-DAD948FE-50BD-429B-84D1-3FD272710693Q39849680-21BFCA6B-B5F5-4AB8-BBDE-8EDB55CA9680Q39849921-E6449E6F-E952-49AC-95EB-187F40134EFAQ39850786-052798DA-E73A-406D-B839-896736D1E180Q39856054-4872D499-12E8-4984-9AEC-F07C8B5095F0Q39856921-F1913279-14B8-4407-ABE2-194C8BAE28E0Q40192467-29B9603F-FA8F-4DAB-91B9-5FEFC3C3FF34Q41912255-0DA9855A-1238-4357-9DBF-71B5AD8D2D82Q42115513-1073FD4D-C15E-4132-8B11-CBF08D7C1BF9Q42929193-B60C1C7B-BB4C-4B46-B47E-25FC210B06D3Q42930469-FBF0373A-888B-4CBA-8C5F-CEEB1C0F5105
P2860
In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh
1981年學術文章
@zh-hant
name
In vitro activity of N-formimi ...... beta-lactamase to resistance.
@en
In vitro activity of N-formimi ...... beta-lactamase to resistance.
@nl
type
label
In vitro activity of N-formimi ...... beta-lactamase to resistance.
@en
In vitro activity of N-formimi ...... beta-lactamase to resistance.
@nl
prefLabel
In vitro activity of N-formimi ...... beta-lactamase to resistance.
@en
In vitro activity of N-formimi ...... beta-lactamase to resistance.
@nl
P2093
P2860
P356
P1476
In vitro activity of N-formimi ...... beta-lactamase to resistance.
@en
P2093
P2860
P304
P356
10.1128/AAC.19.2.248
P407
P577
1981-02-01T00:00:00Z